Beacon Capital Management »

Navidea Biopharmaceuticals shares owned by Beacon Capital Management

Quarter-by-quarter ownership of Navidea Biopharmaceuticals (NAVB) shares owned by Beacon Capital Management from 13F filings

Historical chart of Beacon Capital Management investment in Navidea Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Navidea Biopharmaceuticals held by Beacon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Navidea Biopharmaceuticals by Beacon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1 10 0.10
2023-09-30 $1 10 0.10
2023-06-30 $1 10 0.10
2023-03-31 $3 10 0.30
2022-12-31 $2 10 0.20
2022-09-30 $0 10 0.00
2022-06-30 $0 10 0.00
2022-03-31 $0 10 0.00

More positions owned by Beacon Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Vanguard World Fds Inf Tech Etf (VGT)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Beacon Capital Management

Top funds holding Navidea Biopharmaceuticals

Baader Bank
Parallel Advisors
Advisory Services Network
Beacon Capital Management

View all funds holding Navidea Biopharmaceuticals